Trade GLMD stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Galmed Pharmaceuticals Ltd. (GLMD) is trading at US$4.63, up 0.00% today as of Sep 10, 16:00 EDT. The company has a market capitalisation of US$4.48M. Over the past 52 weeks, GLMD has traded between US$0.41 and US$5.45. On Syfe you can trade GLMD with $0 commission and add it to your watchlist.
| Previous close | US$4.63 |
|---|---|
| Market cap | US$4.48M |
| 52-week range | US$0.41 – US$5.45 |
| Volume | 290.36K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd. is a clinical-stage drug development biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Its product candidate, Aramchol, is a synthetic fatty acid-bile acid conjugate molecule for the oral treatment of NASH in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company was founded by Allen Baharaff and Tuvia Gilat in 2000 and is headquartered in Tel Aviv, Israel.
Year: 2014
Galmed Pharmaceuticals Develops Oral Film Version of Parkinson's Treatment
Jul 28, 12:42 PM · MT Newswires
Galmed Pharmaceuticals Completes Acquisition of Colospan Under Restructured Deal
Jun 22, 1:55 PM · MT Newswires
Galmed Pharmaceuticals Ltd. (GLMD) stock is trading at US$4.63, 0.00% from the previous close of US$4.63.
The market cap for Galmed Pharmaceuticals Ltd. (GLMD) stock is approximately US$4.48M.
The 52-week high for Galmed Pharmaceuticals Ltd. (GLMD) stock is US$5.45.
The 52-week low for Galmed Pharmaceuticals Ltd. (GLMD) stock is US$0.41.
Galmed Pharmaceuticals Ltd. (GLMD) does not currently pay a dividend.
Stay on top of GLMD
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
